Phreesia (NYSE:PHR) Coverage Initiated by Analysts at BMO Capital Markets

BMO Capital Markets initiated coverage on shares of Phreesia (NYSE:PHR) in a research report report published on Thursday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $32.00 target price on the stock.

A number of other analysts have also weighed in on PHR. JMP Securities upped their target price on shares of Phreesia from $30.00 to $34.00 and gave the stock a “market outperform” rating in a research note on Monday, September 8th. KeyCorp lowered their price target on shares of Phreesia from $35.00 to $32.00 and set an “overweight” rating for the company in a report on Wednesday, October 8th. Needham & Company LLC increased their price objective on shares of Phreesia from $29.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, September 5th. Truist Financial lifted their price objective on shares of Phreesia from $35.00 to $36.00 and gave the stock a “buy” rating in a research report on Friday, September 5th. Finally, Canaccord Genuity Group boosted their target price on shares of Phreesia from $34.00 to $38.00 and gave the stock a “buy” rating in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Phreesia currently has an average rating of “Moderate Buy” and a consensus price target of $33.71.

Phreesia Stock Down 3.4%

Shares of NYSE:PHR traded down $0.76 during trading on Thursday, hitting $21.77. The company’s stock had a trading volume of 856,196 shares, compared to its average volume of 600,883. The business has a 50 day moving average price of $23.49 and a two-hundred day moving average price of $25.83. The company has a market capitalization of $1.30 billion, a PE ratio of -51.84 and a beta of 0.74. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.12 and a current ratio of 2.12. Phreesia has a fifty-two week low of $17.07 and a fifty-two week high of $32.76.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.08. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The business had revenue of $117.26 million for the quarter, compared to analysts’ expectations of $116.39 million. During the same period last year, the firm earned ($0.03) earnings per share. The company’s revenue for the quarter was up 14.9% compared to the same quarter last year. Phreesia has set its FY 2026 guidance at EPS. As a group, research analysts expect that Phreesia will post -1.1 EPS for the current fiscal year.

Insider Activity at Phreesia

In other news, insider David Linetsky sold 17,445 shares of Phreesia stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $29.73, for a total transaction of $518,639.85. Following the sale, the insider owned 174,002 shares in the company, valued at approximately $5,173,079.46. The trade was a 9.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Evan Roberts sold 45,147 shares of the company’s stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $32.02, for a total value of $1,445,606.94. Following the completion of the sale, the insider directly owned 727,768 shares of the company’s stock, valued at approximately $23,303,131.36. This trade represents a 5.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 92,244 shares of company stock worth $2,680,720. Insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Phreesia

A number of institutional investors have recently modified their holdings of PHR. Cubist Systematic Strategies LLC acquired a new position in Phreesia in the 1st quarter valued at about $774,000. Farther Finance Advisors LLC grew its stake in shares of Phreesia by 9,375.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after purchasing an additional 3,000 shares during the last quarter. Principal Financial Group Inc. acquired a new position in shares of Phreesia in the first quarter valued at approximately $1,623,000. Deutsche Bank AG raised its stake in shares of Phreesia by 30.6% during the first quarter. Deutsche Bank AG now owns 74,857 shares of the company’s stock worth $1,913,000 after purchasing an additional 17,560 shares during the last quarter. Finally, Acadian Asset Management LLC raised its stake in shares of Phreesia by 105.2% during the first quarter. Acadian Asset Management LLC now owns 225,317 shares of the company’s stock worth $5,754,000 after purchasing an additional 115,527 shares during the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.